SutroVax's Series B Round

SutroVax raised a round of funding on March 21, 2017.

SutroVax is an independent vaccine platform and development company, dedicated to the delivery of conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious disease.…

Articles about SutroVax's Series B Round: